Application of an MRI-Visible Nanoparticle in the Treatment of Acute Liver Injury in Rats
Abstract BACKGROUND Acute liver injury (ALI) is characterized by excessive reactive oxygen species (ROS) accumulation and severe inflammation, lacking effective imaging-guided targeted therapy. PURPOSE or HYPOTHESIS: This study fabricated L-arginine-modified manganese-doped mesoporous polydopamine nanoparticles (AMM NPs) and explored their dual functions of MRI visualization and ROS-scavenging/anti-inflammatory treatment for ALI. POPULATION or SUBJECTS: AML12 hepatocytes and thioacetamide-induced ALI rat models were used. Mn-MPDA NPs (MM NPs) were prepared as the control. ASSESSMENT: The physicochemical properties, cytotoxicity, cellular uptake, and ROS elimination ability of AMM NPs were evaluated. In vivo MRI monitoring, hepatic pathological staining, ROS levels, and serum ALT, AST, TNF-α, and IL-6 were detected to assess imaging performance and therapeutic efficacy. RESULTS AMM NPs exhibited uniform spherical morphology, favorable particle size, stable zeta potential, and satisfactory L-Arg loading capacity and longitudinal relaxivity. AMM NPs showed high biosafety and time-dependent cellular uptake. The intracellular ROS level was significantly reduced by 33.64% in the AMM group (p < 0.001). In ALI models, AMM NPs prominently increased hepatic ΔT1 values for injured liver visualization. After treatment, the inflammatory area, hepatic ROS level, and serum ALT, AST, TNF-α, and IL-6 levels were markedly improved compared with the ALI group (all p < 0.05). DATA CONCLUSION: The synthesized AMM NPs possess excellent biocompatibility, accurate T1-weighted MRI imaging capability, and robust ROS scavenging and anti-inflammatory effects. This nanoparticle provides a promising imaging theranostic strategy for precise diagnosis and treatment of acute liver injury.
Authors
- Zhi Li (ORCID: https://orcid.org/0000-0002-6437-0348)
- Xiaomin Duan
- Xiaojing Liu
- Xiaoyuan Zhou
Institutions
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-17
- DOI
- https://doi.org/10.21203/rs.3.rs-11143492/v1
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- preprint